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ABSTRACT 21	  
Probing the multiplicity of hormone signaling via G protein-coupled receptors (GPCRs) has 22	  
demonstrated the complex signal pathways that underlie the multiple functions these receptors play in 23	  
vivo. This is highly pertinent for the GPCRs key in reproduction and pregnancy that are exposed to 24	  
cyclical and dynamic changes in their extracellular milieu. How such functional pleiotropy in GPCR 25	  
signaling is translated to specific downstream cellular responses, however, is largely unknown. 26	  
Emerging data strongly supports mechanisms for a central role of receptor location in signal 27	  
regulation, via membrane trafficking. In this review, we discuss current progress in our understanding 28	  
of the role membrane trafficking plays in location control of GPCR signaling, from organized plasma 29	  
membrane signaling microdomains, potentially provided by both distinct endocytic and exocytic 30	  
pathways, to more recent evidence for spatial control within the endomembrane system. Application 31	  
of these emerging mechanisms in their relevance to GPCR activity in physiological and 32	  
pathophysiological conditions will also be discussed, and in improving therapeutic strategies that 33	  
exploits these mechanisms in order to program highly regulated and distinct signaling profiles.  34	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INTRODUCTION 35	  
Within any cellular signaling system it is becoming apparent that signal location is a critical 36	  
mechanism for cells to translate complex signaling networks at a spatial and temporal level, into 37	  
specific downstream responses. The membrane trafficking of receptors and the signaling molecules 38	  
they activate, can direct the location of intracellular signals, and has such been viewed as an 39	  
integrated cross-regulatory cellular system (1). Thus, membrane trafficking can regulate many 40	  
fundamental cellular programs and an increasing number of clinical conditions have been reported to 41	  
result from defects in membrane trafficking pathways or cargo sorting (1,2). The role of location in 42	  
signal regulation via membrane trafficking is highly pertinent for the signaling activated by the 43	  
superfamily of G protein-coupled receptors (GPCRs). A well-established contribution that trafficking 44	  
plays in GPCR signaling is the ability to regulate heterotrimeric G protein signal patterns (3). A 45	  
simple but dramatic example is the divergent sorting of GPCRs following ligand-induced endocytosis 46	  
to either recycling or degradative/lysosomal pathways (see Figure 1) a process that essentially 47	  
produces opposite effects on receptor signaling via its cognate G proteins (3). Furthermore, the 48	  
potential to reprogram signaling by altering trafficking or location of receptors may be a key adaptive 49	  
mechanism for GPCRs that are exposed to cyclical and dynamic hormonal environments, such as 50	  
those receptors central to regulating reproduction and pregnancy. In this review, we will highlight the 51	  
recent advances in our understanding that membrane trafficking plays in location control of GPCR 52	  
signaling, focusing where possible, on reproductive-relevant GPCRs, and the potential therapeutic 53	  
application and exploitation of these findings. 54	  
CLATHRIN-COATED PITS-MORE THAN JUST A MODE OF ENDOCYTOSIS? 55	  
The removal of GPCRs from the cell surface, via the process of endocytosis, is well established to 56	  
regulate receptor signaling by contributing to heterotrimeric G protein-signal desensitzation. Several 57	  
pathways have been described to regulate receptor-mediated endocytosis, however, clathrin-mediated 58	  
endocytosis (CME) via clathrin-coated pits (CCPs) is the most extensively characterized. CCPs are 59	  
formed by the recruitment and ordering of clathrin coat proteins with cargo, accessory proteins and 60	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adaptors (Figure 1, B, reviewed in (4,5)). A new vesicle is then formed following the scission of the 61	  
CCP from the membrane by the dynamin family of GTPases (6). The widely accepted model for 62	  
GPCR recruitment to CCPs is that a ligand-activated receptor is first phosphorylated (by a member of 63	  
the family of the GPCR kinases (GRKs)), which increases the affinity of the cytoplasmic adaptor 64	  
proteins arrestin 2 and/or 3 to the receptor. Arrestins have the ability to bind clathrin heavy chain, 65	  
beta(2)adaptin subunit of the clathrin adaptor AP2 and GPCRs, thus facilitating GPCR recruitment 66	  
and clustering into CCPs for their subsequent internalization (reviewed in (7)). In addition to 67	  
uncoupling heterotrimeric G protein signaling from the plasma membrane, arrestins also directly 68	  
activate GPCR signaling independent of their cognate G proteins, by acting as scaffolds for a variety 69	  
of signaling proteins (Figure 1, C). Distinct GPCRs can vary in how they engage in receptor-mediated 70	  
endocytosis including; preferential arrestin recruitment, phosphorylation via distinct kinases, ligand-71	  
independent internalization and even arrestin- and/or clathrin-independent internalization. This has 72	  
been extensively reviewed elsewhere (8-11). Instead we will focus on how these pathways, machinery 73	  
and distinct clathrin-containing plasma membrane domains may enable tight control of cell surface 74	  
organization as a mechanism to exquisitely regulate cell signaling. 75	  
 76	  
The diverse range of cargo and machinery reported to assemble to CCPs has raised the question of 77	  
whether there is heterogeneity in localization across CCPs for different receptors, and in turn whether 78	  
this impacts subsequent sorting and signal activity of a receptor. That distinct receptors may be 79	  
organized within distinct subsets of CCPs was first reported for the β2-adrenergic receptor (β2AR) 80	  
(12). A role for such specialized spatial organization of CCPs was then demonstrated to dictate its 81	  
subsequent sorting to recycling or lysosomal pathways (13), as also shown for the purinergic 82	  
receptors, P2Y(1) and P2Y(12), that identified two distinct CCP populations (14,15) also with 83	  
functional implications in differential post-endocytic sorting. Mechanistically, the targeting of 84	  
receptors to these distinct CCPs was dependent on arrestin and phosphorylation, with P2Y(12) and 85	  
β2ARs recruited in an arrestin and GRK-dependent manner and P2Y(1) in an arrestin-independent yet 86	  
PKC-dependent manner. An additional GPCR well known to internalize via an arrestin-independent 87	  
5	  
	  
manner is the mammalian gonadotropin-releasing hormone receptor (GnRHR (16). Although reported 88	  
to localize to clathrin and caveolae/lipid rafts depending on the cell type (see below), this receptor 89	  
rapidly recycles following ligand-induced internalization (17), unlike the arrestin-independent 90	  
P2Y(1), so it is possible there may be further subspecializations of CCPs that is dictated by 91	  
associating adaptor molecules. The impact of such subspecialization on receptor activity, and 92	  
consequently its downstream physiological function, may be to function as ‘bona fide’ signalling 93	  
microdomains, e.g. via arrestin-dependent signal complexes (Figure 1, C). The potential role of CCPs 94	  
to act as signaling microdomains is highlighted by the ability of GPCRs to regulate their own CCP 95	  
residency time. For the β2AR this is achieved by interaction with additional protein scaffold proteins, 96	  
namely postsynaptic density 95/disc large/zonula occludens-1 (PDZ) proteins, that tether GPCRs to 97	  
cortical actin, and extend the occupancy time of a receptor in a CCP by delaying the recruitment of 98	  
dynamin (15). However, other receptors such as the mu-opioid receptor delay the scission activity 99	  
rather than recruitment of dynamin, and in a PDZ-independent manner (18). Functionally delayed 100	  
residency time of a GPCR in CCPs provides a mechanism to regulate mitogenic signals on a temporal 101	  
scale via formation of arrestin signaling scaffolds, as suggested by a recent study measuring residency 102	  
times with distinct agonists of the cannabinoid CB1 receptor (19). The CB1 cannabinoid receptor, as 103	  
part of the endocanabinoid system, modulates synaptic function, including negative regulation of 104	  
GABAergic input to GnRH neurons, suppressing GnRH output and fertility (20) and thus such spatio-105	  
temporal regulation of CB1 signaling may be key in its role in modulating release of GABA from the 106	  
presynaptic membrane under physiological or pathophysiological conditions, e.g. the ability of 107	  
cannabis drugs to inhibit pituitary LH secretion. Additional downstream cellular consequences for 108	  
tight spatial control of GPCR signalling, such as that generated from CCPs, has been recently 109	  
demonstrated between PAR2 and neurokinin1 (NK1) receptor whose arrestin-dependent ERK 110	  
signaling mediates either cell migration (PAR2) or proliferation (NK1 receptor) via differential ERK 111	  
localization (21). While arrestin-recruitment or post-endocytic trafficking fate of a GPCR could 112	  
dictate the localization of receptors in to distinct CCPs, clathrin-associated adaptors such as arrestin 113	  
and AP-2 represent core CCP machinery utilised by many kinds of receptors, but it is uncertain 114	  
whether there are additional machinery that could direct receptors into distinct pits. It has been 115	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postulated, however, that organization of receptors across CCPs may be initiated via the differential 116	  
phosphorylation of GPCR intracellular domains (22) although it remains to be determined if this 117	  
dictates any adaptor protein specificity in addition to the arrestins.  118	  
 119	  
Lattices and plaques-novel clathrin-containing structures to regulate GPCR signaling in 120	  
reproduction? 121	  
Additional plasma membrane clathrin-coated structures, clathrin plaques and clathrin flat lattices, 122	  
have been recently reported to be potential sites of GPCR organization at the plasma membrane 123	  
(23,24). Although observed by cell biologists for many years, these recent studies have proposed that 124	  
they are perhaps unprecedented signal microdomains for GPCRs. These large and stable clathrin-125	  
coated structures, with distinct morphologies to CCPs, are present in different cell types, and where 126	  
GPCRs such as the β2AR, mu-opioid receptor and the chemokine receptor CCR5 can localize. For 127	  
CCR5, ligand activation specifically reorganized the receptor to flat clathrin lattices. The stable nature 128	  
of these structures compared to CCPs has led to the suggestion it represents a mechanism to 129	  
functionally compartmentalize the activated form of the receptor in the plasma membrane and thereby 130	  
act as a platform for receptor signaling and/or desensitization (24). CCR5 is a key receptor for the 131	  
immune system and although expressed in leukocytes CCR5 and its ligand are found in other cell 132	  
types in the reproductive tract where its expression in human endometrium is thought to regulate 133	  
blastocyst implantation(25). Furthermore presence of the ligand RANTES in follicular fluid and 134	  
CCR5 on human sperm, its role in chemotaxis of human sperm (26) is of interest in patients with 135	  
endometriosis and genital tract inflammatory diseases where high levels of RANTES induces a 136	  
premature acrosome reaction and may underlie the subfertility observed in these patient groups (27). 137	  
These physiological/pathophysiological roles of CCR5 may reflect the impact of a sustained CCR5 138	  
signal profile by localization to such plasma membrane coated structures. Interestingly cell adhesion 139	  
is thought to occur at membrane sites containing these clathrin-coated structures (23,24), and an 140	  
example where clathrin-coated structures are known to exist at sites of inter-cellular interactions are 141	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tubulobulbar complexes in the testes. Tubulobulbar complexes are elongated tubular extensions that 142	  
project either from spermatids or, from Sertoli cells into corresponding invaginations of adjacent 143	  
Sertoli cells at sites of cell/cell junctions (28). Characteristically each membrane complex is capped 144	  
by a clathrin-coated structure that is highly stable and does not undergo scission; features of the more 145	  
stable clathrin lattices and plaques rather than the classic CCPs they are proposed to be (28). No 146	  
GPCRs have been identified to date to be present in these clathrin-coated structures, however, given 147	  
the expression of the FSH receptor in Sertoli cells and the numerous GPCRs that have been reported 148	  
to be expressed in sperm (29-31), they could represent an important spatial mechanism in inter-149	  
cellular communication for GPCRs and spermatocyte translocation and release. 150	  
 151	  
Arrestin-dependent signaling and its role in reproduction 152	  
The ability of arrestin-mediated trafficking to activate cell signaling, in addition to G protein-signal 153	  
desensitization, has been the topic of extensive study for many years and is of current high interest as 154	  
a valid pathway for pharmaceutical targeting with clinical benefits (32,33). Arrestins can link a 155	  
number of effectors to agonist-bound GPCRs, for instance Src family tyrosine kinases, components of 156	  
the MAP kinase cascade (ERK and JNK) and ubiquitin ligases (Mdm2) (34), giving rise to distinctive 157	  
temporal and spatially regulated signaling modes induced by GPCRs. These distinct signal modalities 158	  
provide a mechanism for diversifying signaling via a single class of proteins, and for receptors 159	  
exposed to dynamic hormonal environments, such as those in reproduction and pregnancy, a way to 160	  
potentially reprogram GPCR signal pathways as a physiological adaptive mechanism.  161	  
 162	  
The gonadotropin hormone receptors - follicle-stimulating hormone receptor (FSHR) and luteinizing 163	  
hormone receptor (LHR) – recruit arrestin for desensitization of gonadotropin-hormone induced 164	  
signaling but also activation of non-G protein mediated pathways in the ovary and testis. For LHR, 165	  
the mid-cycle LH surge results in desensitization of Gαs-adenylate cyclase-cAMP signaling in ovarian 166	  
follicles, a process mediated by arrestin 2 and requiring the ADP-ribosylation factor (ARF) 167	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nucleotide-binding site opener (ARNO). ARNO releases arrestin 2 from its membrane-docking site 168	  
and a guanine nucleotide exchange factor of the small G-proteins ADP ribosylation factors (Arfs) 6, 169	  
(ARF6) promotes binding of arrestin to the LHR (35,36). Desensitization of Gαs signaling during the 170	  
LH surge may ‘bias’ the receptor towards other G protein pathways namely Gαq/11, which is 171	  
involved in ovulation (37), and/or MAPK pathways, although the involvement of arrestin in these 172	  
pathways in the ovary remains to be determined. However, arrestin can mediate mitogenic signaling 173	  
from LHR in testicular Leydig cells, where LHR activates MAPK signaling via an arrestin3/Fyn 174	  
complex that releases EGF-like factors to activate ERK (38), furthermore this LH and EGF receptor 175	  
cross-talk is important in driving testosterone production in vivo (39). For FSHR, although it can 176	  
recruit arrestins and GRKs to desensitize its G protein signaling, it can also induce MAPK signaling 177	  
via the arrestins. The ability of FSHR to activate MAPK signalling independent of the cAMP pathway 178	  
likely underlies the subfertility phenotype in an inactivating mutation (A189V) identified in male 179	  
patients that exhibit impaired cAMP signalling but maintain arrestin-dependent ERK activation (40).  180	  
 181	  
GPCR signaling is also tightly controlled during pregnancy and undergoes dramatic adaptive changes 182	  
during labour where oxytocin receptor (OTR) is central to these processes. Arrestin 2 and 3 in the 183	  
mouse myometrium negatively regulates OTR-induced contractions, where arrestin2/3 null mice 184	  
exhibit a lack of OT-induced desensitization (41). Interestingly, in human myocytes, arrestin 2 and 3 185	  
play contrasting roles in signal desensitization and activation of MAPK signalling. Arrestin 2 is 186	  
involved in G protein desensitization while arrestin 3 mediates ERK signaling responses (42). Such 187	  
arrestin-specific regulation may be a mechanism to modulate distinct pro-labor functions of OTR, 188	  
namely contractions and inflammation (43,44). More recently a central role for arrestins in regulating 189	  
hypothalamic-pituitary-gonadal function at the level of the kisspeptin receptor has been demonstrated 190	  
whereby either arrestin 2 or arrestin 3 knockout mouse models exhibited a diminished kisspeptin-191	  
dependent LH secretion (45). This suggests that activation of arrestin-mediated ERK signalling by the 192	  
kisspeptin receptor is an important pathway in reproduction and an explanation why known 193	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inactivating kisspeptin receptor mutations (in terms of Gαq/11 signaling) results in only partial 194	  
gonadotropic deficiency (45). 195	  
 196	  
LIPID RAFTS & CAVEOLAE AS GPCR SIGNALING MICRODOMAINS 197	  
Lipid rafts and caveolae are defined as planar microdomains of the plasma membrane enriched in 198	  
specific lipids and proteins such as cholesterol, sphingolipids and glycosylphosphatidylinositol (GPI)-199	  
anchored proteins or for caveolae, caveolin proteins (Figure 1, Ai). Lipid rafts are known to be 200	  
involved with various cell functions such as cholesterol homeostasis, protein and lipid sorting and 201	  
vesicular transport (46,47). Importantly, they are known to regulate cell signaling at the plasma 202	  
membrane by organizing receptors with its signaling machinery; heterotrimeric G-proteins, effector 203	  
enzymes such as adenylate cyclase, and regulators of G-protein signaling (e.g. RGS16 (48)). Thus, 204	  
disruption of lipid raft formation can abolish signaling from certain GPCRs including the NK1 205	  
receptor (49) and the serotonin 1A receptor (50).  206	  
 207	  
Localization of GPCRs to lipid rafts can occur in a constitutive or ligand-dependent manner. The 208	  
majority of GPCRs exhibit a small amount of constitutive partitioning to lipid rafts, which is then 209	  
increased upon ligand stimulation. However, the murine GnRHR has been shown to exclusively 210	  
reside in cholesterol-rich membrane microdomains in certain cell types (51,52). Mammalian GnRHRs 211	  
are unique to the GPCR superfamily by their lack of an intracellular C-terminal tail, however this has 212	  
been shown to not be the only contributing factor involved in lipid-raft localisation as addition of the 213	  
chicken GnRHR C-terminal tail had no effect on raft localization (53,54). In contrast, the C-terminal 214	  
tail of the non-lipid raft associated LHR could reorganize the GnRHR into non-raft regions of the 215	  
plasma membrane, (53,55), even though LHR has been observed to form ordered plasma membrane 216	  
microdomains following hormone stimulation (56,57). Interestingly pituitary gonadotropes do not 217	  
contain caveloae (54) yet the lipid raft protein flottilin-1 is highly expressed and associates with 218	  
GnRHRs (51), suggesting the nature of the lipid rafts in gonadotropes are distinct. The role of these 219	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microdomains on GnRH-signaling is proposed as a mechanism to compartmentalize calcium signaling 220	  
via L-type calcium channels in gonadotropes as a required element of GnRH-induced ERK signaling. 221	  
More recently, total-internal reflection microscopy (TIRF-M) studies in the gonadotrope cell line 222	  
alphaT3-1, provided direct visual evidence for organised plasma membrane calcium influx events 223	  
termed ‘calcium sparklets’ (58). Ultimately such spatial control of calcium and ERK signaling by 224	  
GnRHR may be required to regulate key functions such as LHβ synthesis and secretion (59). 225	  
Furthermore, they may also represent a platform for receptor cross-talk. Indeed both the 226	  
glucocorticoid receptor and insulin receptors have been reported to localize to GnRHR-containing 227	  
lipid raft/microdomains (53,54) For the glucocorticoid receptor, localization to lipids rafts with 228	  
GnRHR and activation of both receptors was required for the synergistic inhibition of cell 229	  
proliferation via PKC activation and SGK-1 transcription (60). Interestingly, insulin and GnRHR 230	  
containing microdomains exhibit asymmetric functionality, whereby insulin enhances GnRH-induced 231	  
ERK signaling, yet GnRH inhibits activation of insulin-mediated PI3K/Akt signaling pathway (54). 232	  
This study highlights the important contributions of metabolic pathways in reproduction, and 233	  
potentially in conditions such as polycystic ovarian syndrome (PCOS) where hyperinsulinaemia could 234	  
be coupled to the high circulating LH levels found in subsets of women with PCOS (61). However, 235	  
the majority of such studies are carried out under sustained treatments of GnRH, yet GnRH 236	  
stimulation is both pulsatile and dynamic, and this has been recently shown to impact on its MAPK 237	  
signaling (62). Therefore an important next step is to understand how these microdomains contribute 238	  
to its signaling responses under such dynamic conditions in vivo. 239	  
 240	  
Despite the caveats involved in the biochemical study of lipid rafts (for review please see (63) the 241	  
identification that caveolae contain caveolin proteins Cav1, -2, and/or -3 (the latter being muscle-242	  
specific) (64), provided a molecular ‘tag’ to study these microdomains. Certain GPCRs have reported 243	  
to internalize via caveolae, although the molecular detail in how this process occurs is not well 244	  
understood (65). However, like lipid rafts, they can also act as GPCR signalosomes, both as a means 245	  
to spatially desensitize and also locally amplify signal responses. Many GPCRs, G-protein subunits 246	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and effector enzyme systems have been shown to be sequestered by caveolae (66,67). One example of 247	  
a signaling complex mediated by Cav-1 is that of Gαq and phospholipase C, which results in elevated 248	  
levels of inositol triphosphate (68). Such enhancement of Gαq signaling may underlie the caveolae-249	  
dependent anti-proliferative action of OTR in prostatic stromal cells with implications in the 250	  
dysregulation of this pathway in aging and prostate cancer (69).  251	  
 252	  
PLASMA MEMBRANE ORGANISATION OF RECYCLED RECEPTORS 253	  
Following GPCR endocytosis, many receptors are targeted to a recycling pathway back to the plasma 254	  
membrane, resulting in resensitisation or recovery of hormone signaling (Figure 1, F). GPCRs are 255	  
sorted to the recycling pathway via a sequence-directed mechanism requiring specific cis-acting 256	  
sorting sequences in their carboxy-terminal tails (3,70,71). This is in contrast to receptors that recycle 257	  
in the absence of sorting sequences and occur in a ‘default’ manner via the bulk membrane flow. For 258	  
some receptors such as the β2-AR, recycling sequences are type 1 PDZ ligands (72,73) and β2AR 259	  
associates with the PDZ protein SNX27 for its post-endocytic trafficking (74). However the high 260	  
diversity in recycling sequences across GPCRs suggests they bind specific cytoplasmic proteins (3). 261	  
We refer the reader to reviews describing the endosomal mechanisms mediating post-endocytic 262	  
sorting to these pathways via highly diverse GPCR recycling sequences (3,70). In terms of plasma 263	  
membrane organization of GPCR signaling, recent reports studying the events downstream of 264	  
endosomal sorting of GPCRs back to the plasma membrane may indicate that such pathways could 265	  
direct receptors to defined plasma membrane domains. Such studies have employed N-terminal 266	  
labeling of GPCRs with superecliptic pHluorin (which is fluorescent at neutral pH and non-267	  
fluorescent at acidic pH (pH < 6.0) that occurs within the acidic lumen of the endosome), coupled 268	  
with TIRF-M imaging and has enabled direct visualization of individual receptor insertion events into 269	  
the plasma membrane at high temporal resolution (71,75,76). The β2AR and mu-opioid receptor both 270	  
undergo sequence-directed recycling and these studies imaging individual recycling events revealed 271	  
that GPCR recycling; 1) occurs at a much faster rate following ligand stimulation than previously 272	  
detected by other approaches and 2) exhibited distinct spatial-temporal patterns of insertion. Both 273	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transient and ‘persistent’ insertion events of receptor containing vesicles have been described, the 274	  
former remaining for <1 second, while the persistent for >10 seconds before the receptor laterally 275	  
diffuses in to the membrane. The type of events exhibited seems to be cell-type-dependent as the 276	  
persistent events were primarily a feature of neurons and not in heterologous cell lines such as HEK 277	  
293 cells or astrocytes and fibroblasts (75,77). It remains to be determined if other cell types exhibit 278	  
these kind of persistent fission events and what functional role they may play, although, a role for 279	  
these events as specialized signaling complexes has been proposed (75). Interestingly, both recycling 280	  
events seem to be regulated by distinct mechanisms, with the transient events negatively regulated by 281	  
PKA and agonist, while the persistent is positively regulated by agonist yet PKA-independent. Given 282	  
the role of GPCR-induced cAMP-PKA signaling in these recycling events, one possible signaling 283	  
complex involved in regulating and/or perhaps integrating a functional response from these newly 284	  
recycled receptors are the A-kinase anchoring proteins (AKAPs). 285	  
 286	  
The AKAPs are a large family of scaffolding proteins that facilitate GPCR signaling by binding to the 287	  
regulatory subunits of the PKA via their C-terminal motif (reviewed in (78,79)). In addition to the 288	  
ability of AKAP to interact with PKA, AKAPs are also known to mediate signal transduction by 289	  
scaffolding signaling machinery such as adenylate cyclase and other kinases, such as serine/threonine 290	  
and tyrosine kinases, as well as signal termination molecules such as phosphatases and 291	  
phosphodiesterases. Therefore, AKAP can form specialized signaling microdomains or stations, 292	  
which can allow spatio-temporal regulation of signaling. AKAPs such as AKAP12 (also termed 293	  
Gravin or AKAP250) have been shown to preferentially associate with the β2AR at the plasma 294	  
membrane and are involved in regulating the recycling of this GPCR (80,81). Additional AKAPs 295	  
implicated in regulation of β2AR receptor activity are AKAP5 (also termed AKAP79/150), which 296	  
interestingly is specifically required for ERK activation without affecting cAMP signaling or 297	  
recycling (82). Whether such scaffolding proteins could reflect a potential functional role of persistent 298	  
and/or transient recycling events remains to be determined. However, AKAP5 and 7alpha have been 299	  
implicated in maintaining oocyte meiotic arrest, and as both constitutive endocytosis and recycling are 300	  
required of the GPCRs responsible for maintaining this cAMP signaling (GPR3/6/12), suggests that 301	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spatial scaffolding of cAMP signaling of these recycling GPCRs is important in oocyte maturation 302	  
(83-85) 303	  
 304	  
ENDOSOMAL GPCR SIGNALING 305	  
As described above the paradigmatic model of GPCR signaling used to be depicted as plasma 306	  
membrane localized receptors activating a distinct heterotrimeric G protein signaling pathway that in 307	  
turn converges on to common downstream pathways, such as MAPK signaling. Our current 308	  
understanding of the high complexity in these pathways now include the well-described ability of key 309	  
GPCR adaptor proteins, i.e. arrestins, in generating distinct signaling patterns at specific membrane 310	  
locations. However, more recently there has been an emerging body of data demonstrating that G 311	  
protein signaling from receptors can occur beyond the plasma membrane (i.e. at the level of 312	  
endosomes) and that signaling could be regulated across endosomal populations, thus GPCR signaling 313	  
can therefore be broadly categorized in to two phases: plasma membrane signaling (phase 1) and 314	  
endomembrane signaling (phase 2) (see Figure 1). Pivotal studies demonstrating that GPCRs continue 315	  
to activate, or exhibit persistent, heterotrimeric G protein signaling following internalization was 316	  
shown with two Gαs-coupled receptors, the thryotropin-stimulating hormone receptor (TSHR) and 317	  
the parathyroid hormone receptor (PTHR). These studies employed cAMP biosensors (Epac1-camps) 318	  
that demonstrated persistent cAMP signaling requires internalization, the machinery to generate such 319	  
persistent cAMP signals, Gαs and adenylate cyclases, were localized in early endosomes and that this 320	  
persistent endosomal signaling is potentially physiologically relevant (as demonstrated for TSHR in 321	  
3D cultures of thyroid follicles) (86,87). For PTHR, endosomal cAMP generation was shown to be 322	  
enhanced by arrestin and attenuated by the retromer complex involved in receptor recycling (88) and 323	  
that endosomal acidification plays a key role in this deactivating switch (89). The PTHR has critical 324	  
roles in regulating Ca2+ homeostasis by its actions on bone and kidney, and the sustained signalling 325	  
induced by distinct PTH ligands in turn impacts on trabecular bone volume but induces greater 326	  
increases in cortical bone turnover. Such features of PTHR signalling may be exploited 327	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therapeutically such as in certain forms of hypoparathyroidism that respond to PTH. However, the 328	  
authors propose that the PTH analogs that induce sustained signalling lead to enhanced cortical bone 329	  
turnover, thus conditions such as osteoporosis may not benefit from PTH ligands with sustained 330	  
signalling properties (90).  331	  
 332	  
Direct evidence that a GPCR can activate heterotrimeric G proteins from endosomes came from a 333	  
seminal study that developed a nanobody biosensor to detect either the active, nucleotide free form of 334	  
Gαs or the ligand-activated conformation of the β2AR (91). These nanobodies were originally 335	  
generated as tools to aid crystallization of this GPCR in distinct active conformations (92), but the 336	  
application as a biosensor for imaging in live cells revealed that β2AR and Gαs were reactivated upon 337	  
reaching the early endosomal membrane (91). The functional role of this endosomal Gαs-cAMP 338	  
signaling has been recently demonstrated to activate distinct downstream transcriptional responses 339	  
(93). Interestingly, through the use of optogenetic adenylate cyclase probes targeted to either plasma 340	  
membrane, endosome or cytoplasm, these transcriptional responses were mediated entirely by the 341	  
location of the cAMP signal (93), possibly suggesting that endosomally generated cAMP is ‘marked’ 342	  
by as yet unknown mechanisms for the cell to translate these events in to changes in expression of 343	  
specific genes.  344	  
 345	  
The spatial organization of second messenger signaling is likely to be important in a wider 346	  
physiological context and for other GPCRs and G protein pathways. Indeed, sustained endosomal 347	  
cAMP signaling has been also been reported for the glucagon-like peptide 1 receptor (GLP-1R) with a 348	  
requirement in glucose-stimulated insulin secretion (94) (95), the V2 vasopressin receptor with roles 349	  
in regulating renal water and sodium transport and the differential antidiuretic effect between 350	  
vasopressin and oxytocin (96),  the pituitary adenylate cyclase activating polypeptide (PACAP) type 1 351	  
receptor with roles in PACAP-induced neuronal excitability (95) and potentially the prostaglandin E2 352	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receptor EP4 in order to stimulate production of amyloid-beta peptides that are involved in the 353	  
pathogenesis of Alzheimer’s Disease (97). 354	  
 355	  
Endosomal G protein signaling is also relevant for reproductive systems as has been demonstrated for 356	  
the kisspeptin receptor, a Gαq/11 coupled GPCR that exhibits a persistent calcium signaling profile in 357	  
CHO cells and the hypothalamic GnRH expressing neuronal cell line GT1-7 (98). This persistent 358	  
signal was entirely dependent on receptor internalization (98) and may in part underlie the enhanced 359	  
activity of the R386P kisspeptin receptor mutation, that causes central precocious puberty, due to its 360	  
decrease in receptor degradation/downregulation and net increase in recycling, and potentially 361	  
enhanced endosomal calcium signaling (99). Interestingly, this study also demonstrates that 362	  
endosomal signaling from a GPCR can occur for additional G protein pathways. 363	  
 364	  
Spatial Regulation of GPCR Signaling Across Divergent Endosomes-the Very Early Endosome 365	  
Conventionally, the early endosome is viewed as both the earliest and primary platform for receiving, 366	  
organizing, and sorting diverse sets of cargo, however our recent work has demonstrated that two 367	  
Gαs-coupled GPCRs, that undergo sequence-directed recycling, the β2AR and the human LHR 368	  
(rodent LHRs lack the recycling sequence and are primarily sorted for degradation (100) are 369	  
differentially sorted to distinct endosomal compartments. The β2AR is well known to rapidly 370	  
internalize and sort from early endosomes, however, the LHR internalized to a physically smaller 371	  
endosome compartment devoid of early endosomal markers EEA1 and phosphatidylinositol-3 372	  
phosphate. The endosomal size and biochemical content suggested the LHR internalizes to a distinct 373	  
compartment upstream of the early endosome (101). It is known that a subpopulation of early 374	  
endosome intermediates exist that are considered precursors of classic sorting endosomes and notably 375	  
recruit the effector protein of the GTPase Rab5, APPL1 (Adaptor protein containing PH domain, PTB 376	  
domain and Leucine zipper motif) (102). Although LHR was found to traffic to APPL-positive 377	  
endosomes, this receptor does not require Rab5 for its activity suggesting that the pre-early 378	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endosomes that LHR traffics to may be a distinct compartment (101). Routing of the LHR to this 379	  
smaller pre-early endosomal compartment was dependent on the receptor interacting with the PDZ 380	  
protein Gαi-interacting protein C-terminus (GIPC), which was previously shown to interact with the 381	  
LHR C-tail and required for its recycling (103). These studies are complementary as a loss of this 382	  
interaction inhibits LHR recycling due to the rerouting of this receptor away from pre-early 383	  
endosomes to early endosomes. This indicated a sorting requirement for this compartment and hence 384	  
may represent a very early endosome (VEE) (Figure 1, D). It also demonstrated that sequence-385	  
directed sorting of GPCRs can occur from compartments other than the early endosome, as has also 386	  
been demonstrated recently for the β1-adrenergic receptor (β1AR) (104). 387	  
 388	  
The very early endosome also provided a mechanism for direct spatial control of GPCR signaling. 389	  
LH-induced activation of the LHR induced a sustained temporal profile of ERK signaling that 390	  
required both internalization and targeting to the correct endosomal compartment, the very early 391	  
endosome (101). Thus, in addition to the compartmental bias in heterotrimeric G protein signaling 392	  
between the plasma membrane and early endosomes described in the studies above, there is also 393	  
compartmental bias in GPCR signaling across distinct endosomes. APPL endosomes have been 394	  
shown to act as signaling centers to regulate the MAPK and Akt signaling cascades by EGFR, 395	  
adiponectin and TrkA receptors and could be crucial for cell survival in some systems (105-109). For 396	  
LHR, the downstream role of very early endosomal targeting remains to be determined, however LH 397	  
does induce a sustained ERK signaling profile in human granulosa cells that negatively regulates 398	  
aromatase expression (110), a signaling profile that may result from localization to and trafficking 399	  
from very early endosomes. However, the known hyperandrogenemia that is one of the diagnostic 400	  
hallmarks of PCOS may be a result of altered LHR endosomal location or retention in very early 401	  
endosomes that could result in altered or enhanced signal profile leading to the known increased 402	  
androstenedione production by LHR in theca cells(111,112);.  403	  
 404	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The very early endosome may be key in regulating activity for GPCRs in addition to the LHR, as has 405	  
been shown for the β1AR and the FSHR (101). Although the β1AR is a known GIPC-interacting 406	  
GPCR (113), the requirement of GIPC in FSHR signaling has not been reported, although APPL1 is a 407	  
well-known binding partner of FSHR (114) and APPL1 and GIPC can also associate (108) suggesting 408	  
a possible mechanism of very early endosomal regulation by these GPCRs. Overall the finding that 409	  
distinct endosomes can confer defined spatial control of receptor signaling provides a cell system 410	  
where hormonal signaling could be altered by simply rerouting receptors between compartments 411	  
under both physiological and pathophysiological conditions. 412	  
 413	  
CONCLUDING REMARKS AND FUTURE DIRECTIONS 414	  
Spatial control of GPCR signaling is more than just an emerging concept but now a working cellular 415	  
model (Figure 1) that now can be employed to understand how cells translate complex signaling 416	  
responses into defined cellular programs in vivo. However, the molecular details of these pathways for 417	  
a given receptor are likely to be even more complex. A detailed understanding of these fundamental 418	  
cell biological mechanisms will likely accelerate with advances in imaging technology such as the 419	  
broad spectrum of super-resolution microscopy approaches that are currently being employed, 420	  
enabling visualization of proteins below the diffraction barrier of standard immunofluorescence 421	  
microscopy, including TIRF-M, and even its adaptation to studying molecular processes directly in 422	  
vivo (115). 423	  
 424	  
GPCRs remain one of the most successful drug targets, and harnessing or manipulating the spatial 425	  
control of GPCR signaling is already being targeted for novel therapeutic strategies. Biased ligands 426	  
are of current high interest with some in clinical development (116,117). Such compounds can 427	  
stabilize a subset of multiple possible receptor conformations, leading to high selectivity in its action 428	  
and potentially fewer off target effects. These ligands can target either orthosteric or allosteric binding 429	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sites in the receptor, or even intracellular regions of the receptor as shown recently through the use of 430	  
intrabodies or pepducins (120-123). Currently this pharmacological ‘tool box’ targets signal bias 431	  
between distinct G protein pathways or, between G protein and arrestin-mediated signaling. As the 432	  
mechanisms and physiological roles of spatial control of GPCR signaling are understood, current 433	  
compounds could be further refined, to accommodate the new information on these pathways and/or 434	  
represent a platform to screen for novel ligands with highly defined properties in directing receptor 435	  
location and thus spatial changes in GPCR signaling. Furthermore, endogenous hormones could be 436	  
biased ligands, such as the distinct glycosylation variants of hCG and FSH that are known to have 437	  
distinct biological activities (118,119). In terms of pharmaceutical development in targeting 438	  
reproductive-relevant receptors, a number of small molecule allosteric compounds to GnRHR, LHR 439	  
and FSHR have been developed (124,125). While the pharmacochaperone properties of some of these 440	  
compounds, such as those to GnRHR, have been well described (126), the role of these small 441	  
molecules in spatial control or biased signaling remains to be determined. In addition to drug design, 442	  
the approach that is used to characterize GPCR mutations or polymorphisms must also be revised to 443	  
incorporate these latest models of GPCR signaling, such as has been demonstrated with the A189V 444	  
FSHR mutation (40) and the R386P kisspeptin receptor mutation, that causes central precocious 445	  
puberty (99). 446	  
 447	  
In summary, spatial organization and thus the cellular location of a GPCR, can program the 448	  
multidimensionality of GPCR signaling into highly regulated and distinct signaling profiles, a 449	  
property that is highly advantageous for dynamic hormone signaling. Efforts must now be directed to 450	  
exploit this new information in order to provide important insight in to complex diseases and 451	  
conditions such as PCOS, gonadotropin-dependent cancers and pre-term labour, and improving 452	  
therapeutic strategies that incorporates the full pleiotropic nature of these receptors. 453	  
 454	  
 455	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GnRHR gonadotropin-releasing hormone receptor 469	  
GRKs  GPCR kinases 470	  
LHR  luteinizing hormone receptor 471	  
MAPK  mitogen activated protein kinase 472	  
NK1  neurokinin-1 473	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FIGURE LEGEND 848	  
Figure 1. A cellular model for spatial control of GPCR signaling across the plasma membrane 849	  
and endomembrane system. Following agonist binding, GPCRs can be directed into distinct plasma 850	  
membrane microdomains such as lipid rafts (Ai) or, following activation and subsequent 851	  
desensitisation (Aii), several GPCRs are known to undergo endocytosis via clathrin-dependent or 852	  
independent mechanisms (B). Clathrin-coated pits (CCPs) allow accumulation of GPCR/arrestin 853	  
complexes that can activate arrestin-mediated mitogenic signaling (C). Following internalization, 854	  
GPCRs will accumulate in endosomal compartments where they can continue or reactivate 855	  
heterotrimeric G protein signaling from the endosomal membrane, in addition to scaffolding arrestin 856	  
to activate G protein-independent signal responses (D & E). Some GPCRs are differentially sorted to 857	  
a distinct endosomal population termed pre-EEs or very early endosomes (VEEs) (D), via recruitment 858	  
and binding of the PDZ protein GIPC at the CCP. The VEE sorts receptors to the regulated, sequence-859	  
directed plasma membrane recycling pathway and targeting of GPCRs to this compartment generates 860	  
a sustained MAPK signaling response, although it is unknown if other pathways, including G protein 861	  
signaling are activated in this compartment. Other GPCRs are directly routed to the early endosome 862	  
(EE), where they are differentially sorted between recycling and degradative/lysosomal pathways, 863	  
leading to heterotrimeric G protein plasma membrane signal resensitization or signal termination 864	  
respectively. Reinsertion in to the plasma membrane of GPCRs targeted to the recycling pathway (F) 865	  
exhibits distinct spatial-temporal patterns of insertion, either transient or persistent (see text), although 866	  
its role in spatial control of signaling in addition to resensitization is unknown. 867	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